|
WO2021018774A1
|
|
Ergothioneine, s-methyl-ergothioneine, and uses thereof
|
|
WO2020245076A1
|
|
Eph2a aptamer and uses thereof
|
|
WO2020144332A1
|
|
Fusion protein with immunosuppressive activity
|
|
EP3808763A1
|
|
Compounds for immunomodulation
|
|
HK1244679A1
|
|
Oncolytic adenoviruses for treating cancer
|
|
EP3384923A1
|
|
C4bp-based compounds for treating immunological diseases
|
|
EP3331514A1
|
|
Rectal topical lipogel comprising an anesthetic agent and a non-steroidal anti-inflammatory agent for pain relief
|
|
CN107923897A
|
|
Method and composition for diagnose and treat adrenoleukodystrophy
|
|
BR112016022582A2
|
|
Mitochondrial markers of neurodegenerative diseases
|
|
AU2012380717A1
|
|
Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis
|
